Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review
Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review is a paper indexed in PICO Portal from OpenAlex.
How many citations does Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review have?
Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review has 74 citations in the OpenAlex counts PICO Portal stores.
When was Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review published?
Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review has 2011 year in the PICO Portal index.
What is the open-access status of Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review?
Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review has green oa status in the PICO Portal index.
What is the DOI of Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review?
The DOI for Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review is on the source record.
What is the PMID of Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review?
The PMID for Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review is on the source record.
What is the OpenAlex record for Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review?
The OpenAlex for Validity of biomarkers predicting onset or progression of nephropathy in patients with Type 2 diabetes: a systematic review is on the source record.